F01 in the Treatment of Moderate-to-severe Refractory Systemic Lupus Erythematosus
Clinical trial NCT06468683 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06468683
- Sponsor
- Shanghai Simnova Biotechnology Co.,Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-15
- Primary completion
- 2027-01-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.